Digemid reported that the first corporate purchase of state will also acquire FARMC against diabetes more than S/.2.7 million. Such purchases has earned a 30% saving on prices. (USI)
In order to ensure access to low priced medicines for people with cancer and HIV, the State will invest S/.20 million soles to buy these products, and more than 2.7 million suns for diabetes drugs. These three diseases are chronic and incurable.
This is possible thanks to the first corporate purchase in 2011 by the State, which also permit a reduction in prices of up to 30%, the Digemid.
"S/.11 be allocated '959, 000 to buy oncology treatment S/.8 '007, 000 to treat HIV, and S/.2 '790, 000 for diabetes. In total is more than S/.22 million, "said the executive director of Access and Use of Drugs in the Digemid, Pedro Yarasca.
is estimated to be purchased together about 70 million units of these medicines, which will be distributed in a timely public health facilities to meet needs of patients.
in these purchases include the Ministry of Health, Essalud, healings of the Armed Forces and National Police (Fospoli), INPE, and the Municipal Hospital of Los Olivos.
"Thanks to corporate purchases, the State has achieved savings of 300 million soles. In addition, this process helps to lower the final price of drugs up to 30%, as pharmaceutical companies competing in the shopping offer their products to lower prices, "he said. Among
oncology products to be purchased are: Anastrozole, bleomycin, capecitabine, carboplatin, cyclophosphamide, cyproterone, Dacarbazine, Imatinib, Paclitaxel. For HIV, has been included to Abacavir, Efavirenz, Stavudine, Lamivudine, Ritonavir, Saquinavir, Zidovudine, among others. And diabetes, glibenclamide and metformin.
The total amount of the first Inter-Corporate Purchase of 2011 (which includes drugs for other diseases) is S/.344 '076, 132.87.
http://peru21.pe/noticia/711216/compran-medicinas-cancer-vih-20-mllns
0 comments:
Post a Comment